Corazao-Rozas, Paola <br/><br/>
Mitochondrial oxidative phosphorylation controls cancer cell's life and death decisions upon exposure to MAPK inhibitors.  [electronic resource] 

 -  Oncotarget  Jun 2016 
 - 39473-39485 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.7790  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Azetidines--pharmacology<br/>Calcium--chemistry<br/>Cell Death--drug effects<br/>Cell Line, Tumor<br/>Drug Resistance, Neoplasm--drug effects<br/>Endoplasmic Reticulum--metabolism<br/>Female<br/>GTP Phosphohydrolases--metabolism<br/>Gene Silencing<br/>Humans<br/>Indoles--pharmacology<br/>MAP Kinase Signaling System<br/>Melanoma--drug therapy<br/>Mice<br/>Mice, SCID<br/>Mitochondria--metabolism<br/>Mitochondrial Proteins--metabolism<br/>Neoplasms--enzymology<br/>Oxidative Phosphorylation<br/>Piperidines--pharmacology<br/>Protein Kinase Inhibitors--pharmacology<br/>Proto-Oncogene Proteins B-raf--genetics<br/>RNA Interference<br/>Sulfonamides--pharmacology<br/>Treatment Outcome<br/>Vemurafenib